During the past decade, The Ohio State University Department of Psychiatry conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 10 clinical trials were completed. i.e. 1000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Ohio State University Department of Psychiatry" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "Forest Laboratories" with 3 trials sponsored, "Allergan" with 1 trials sponsored, "Assurex Health Inc." with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University Department of Psychiatry" #1 collaborator was "University of Michigan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Ohio State University Department of Psychiatry" are "Depressive Disorder, Major" (4 trials), "Major Depressive Disorder" (4 trials), "Bipolar Disorder" (1 trials), "Cognitive Impairment Associated With Schizophrenia" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "The Ohio State University Department of Psychiatry" in a lesser frequency.

Most popular intervention types in "The Ohio State University Department of Psychiatry" are "Drug" (11 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Rapastinel" (4 trials), "Fluoxetine" (2 trials), "Vilazodone" (2 trials) and "BIIB104" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University Department of Psychiatry" are 12 trials for "All" genders.

Currently, there are NaN active trials in "The Ohio State University Department of Psychiatry". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in The Ohio State University Department of Psychiatry, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University Department of Psychiatry, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".